June 26th 2020 Julia Kuzmenko, Associate in Lidings’ Corporate and M&A practice will run an online-seminar on the legal aspects of telemedicine, organized by Sobytie conference center.

The State Duma of the Russian Federation adopted the Law¹ in the third reading which provides the opportunity to require early termination of leases for tenants affected by the deteriorating economic situation resulting from the spread of a new coronavirus infection. The final version of the Law in this part has undergone multiple fundamental changes.

This refers to the fast track registration and conduct of clinical trials, which is valid until January 1, 2021 and is worked out for medical drugs potentially effective in the fight against COVID-19.

May 27th 2020 Julia Kuzmenko, Associate in Lidings’ Corporate and M&A practice, will take part in ONLINE PHARMA ADVANCE CONFERENCE organized by Business Summit of Future.

Now parties can add up the idea of how to exercise the right to defer debt repayment under lease agreement.

The Moscow Mayor Decree dd 04.04.2020 No. 39-UM “On amendments being made to the Moscow Mayor decree dd 05.03.2020 No. 12-UM” (“Mayor Decree”) stipulates a number of amendments.

Deputies of the State Duma adopted the Law “On making amendments to certain legal acts of the Russian Federation on the prevention and liquidation of emergency situations” in terms of regulating relations arising in connection with the need for emergency response to calls related to the spread of coronavirus infection (“Law”).

On March 3, 2020, the Russian Government introduced to the State Duma the Draft Law on amendments to the Russian Civil Code, namely, article 1360.1.

The coronavirus outbreak (hereinafter referred to as “COVID-19”) served as a trigger for a targeted effort to assess and manage the possible effects of COVID-19.

The year 2019, which continued the trend of rapid and numerous changes in healthcare regulations, was rich on expectations, events and legislative proposals aiming to reverse pharmaceutical industry: medical drugs labeling, reform of price determination, new procedure of entry into drugs civil circulation, amendments to regulatory framework of the Eurasian Economic Union, etc. This trend is likely to continue in 2020 as well.